Wendler J, Lewis RI, Kutilina A, Knott M, Isbell LK, Valk E, Borchmann P, Heger J-M, Illerhaus G, Schorb E. Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma. haematol [Internet]. 2025Jun.1 [cited 2025Jun.23];110(6):1384-8. Available from: https://haematologica.org/article/view/11907